As new therapies and biosimilars flood the market, commercial leaders face a challenge: how to stand out while still delivering personalized care. In an interview with Fierce, Ankit Jain, CEO and co-founder of Infinitus, said the key is creating communication strategies that make each patient feel understood. “It’s about not just one size fits all,” Jain said. “It’s about one size for every patient.” Infinitus, the first agentic healthcare communications partner that safely automates clinical and administrative conversations at scale, aims to give patients and caregivers proactive, tailored information that anticipates their needs.
Jain emphasized that patients want more than generic brochures—they want practical, timely answers about how therapies affect daily life. With many unable to reach providers after hours, AI can bridge the gap by offering safe, natural interactions with guardrails to prevent misinformation. Jain noted that Infinitus technology is already deployed at scale, showing measurable improvements in patient experience and adherence. Watch the full interview to hear his insights on how commercial teams can build trust, reduce friction in care journeys, and deliver support in multiple languages.
Jain emphasized that patients want more than generic brochures—they want practical, timely answers about how therapies affect daily life. With many unable to reach providers after hours, AI can bridge the gap by offering safe, natural interactions with guardrails to prevent misinformation. Jain noted that Infinitus technology is already deployed at scale, showing measurable improvements in patient experience and adherence. Watch the full interview to hear his insights on how commercial teams can build trust, reduce friction in care journeys, and deliver support in multiple languages.